v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 5,888 $ 7,822
Investments 864 925
Accounts receivable, net 27,846 17,722
Inventories 5,083 5,645
Other current assets 2,667 2,169
Assets of businesses held for sale 6,874 3,068
Total current assets 49,222 37,351
Long-term investments 15,270 17,985
Reinsurance recoverables 4,557 4,835
Property and equipment 3,594 3,695
Goodwill 44,374 44,259
Other intangible assets 29,791 30,863
Other assets 3,180 3,421
Separate account assets 7,651 7,430
Assets of businesses held for sale, non-current 0 2,922
TOTAL ASSETS 157,639 152,761
Liabilities    
Current insurance and contractholder liabilities 5,477 5,514
Pharmacy and other service costs payable 28,801 19,815
Accounts payable 8,515 8,553
Accrued expenses and other liabilities 8,920 9,955
Short-term debt 2,572 2,775
Liabilities of businesses held for sale 2,775 2,104
Total current liabilities 57,060 48,716
Non-current insurance and contractholder liabilities 10,573 10,904
Deferred tax liabilities, net 6,794 7,173
Other non-current liabilities 3,033 3,441
Long-term debt 30,230 28,155
Separate account liabilities 7,651 7,430
Liabilities of businesses held for sale, non-current 0 591
TOTAL LIABILITIES 115,341 106,410
Contingencies — Note 16
Redeemable noncontrolling interests 0 107
Shareholders' equity    
Common stock [1] 4 4
Additional paid-in capital 31,186 30,669
Accumulated other comprehensive loss (2,163) (1,864)
Retained earnings 42,480 41,652
Less: Treasury stock, at cost (29,412) (24,238)
TOTAL SHAREHOLDERS' EQUITY 42,095 46,223
Other noncontrolling interests 203 21
Total equity 42,298 46,244
Total liabilities and equity $ 157,639 $ 152,761
[1] Par value per share, $0.01; shares issued, 402 million as of September 30, 2024 and 400 million as of December 31, 2023; authorized shares, 600 million.